CCXI
ChemoCentryx Inc
Price:  
51.99 
USD
Volume:  
2,480,360.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

CCXI WACC - Weighted Average Cost of Capital

The WACC of ChemoCentryx Inc (CCXI) is 8.4%.

The Cost of Equity of ChemoCentryx Inc (CCXI) is 8.35%.
The Cost of Debt of ChemoCentryx Inc (CCXI) is 8.85%.

Range Selected
Cost of equity 6.90% - 9.80% 8.35%
Tax rate 26.20% - 27.00% 26.60%
Cost of debt 7.00% - 10.70% 8.85%
WACC 6.9% - 9.8% 8.4%
WACC

CCXI WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.66 0.89
Additional risk adjustments 0.0% 0.5%
Cost of equity 6.90% 9.80%
Tax rate 26.20% 27.00%
Debt/Equity ratio 0.01 0.01
Cost of debt 7.00% 10.70%
After-tax WACC 6.9% 9.8%
Selected WACC 8.4%